David Collins (Owner, Family And General Dentistry)
Professional information
Musician At Indianapolis Symphony Orchestra
Position:
Musician at Indianapolis Symphony Orchestra
Location:
Indianapolis, Indiana Area
Industry:
Music
Work:
Indianapolis Symphony Orchestra
-
Musician
Director, Pharmaceutical Sciences R&Amp;D At Eli Lilly And Co
Position:
Director, Pharmaceutical Sciences R&D at Eli Lilly and Co
Location:
Indianapolis, Indiana Area
Industry:
Pharmaceuticals
Work:
Eli Lilly and Co
-
Director, Pharmaceutical Sciences R&D
Manager At Texas Roadhouse
Position:
Manager at Texas Roadhouse
Location:
Indianapolis, Indiana Area
Industry:
Food & Beverages
Work:
Texas Roadhouse
-
Manager
Education:
Marian College 2006 - 2009
Business, Business and Finance
Composition And Method For Treating Inflammatory Diseases
US Patent:
6733753, May 11, 2004
Filed:
Feb 15, 2001
Appl. No.:
09/784623
Inventors:
Thomas C. Boone - Newbury Park CA Susan Hershenson - Newbury Park CA Michael P. Bevilacqua - Boulder CO David S. Collins - Fishers IN
Assignee:
Amgen Inc. - Thousand Oaks CA
International Classification:
A61K 3800
US Classification:
4241341, 514 12, 530324
Abstract:
A protein which exhibits a therapeutic effect on inflammation and is useful for treating IL-1-mediated inflammatory diseases, particularly diseases of the joint.
David Fox Collins, Indianapolis IN
Specialties:
Dentist
Address:
3049 N High School Rd, Indianapolis, IN 46224
Dr. David F Collins, Speedway IN - DDS (Doctor of Dental Surgery)
Specialties:
Dentistry
Address:
3049 N High School Rd, Speedway 46224 (317) 293-0471 (Phone), (317) 293-0472 (Fax)
Languages:
English
Trainer At Esi
Position:
Trainer at ESI
Location:
Indianapolis, Indiana Area
Industry:
Pharmaceuticals
Work:
ESI
-
Trainer
Composition And Method For Treating Inflammatory Diseases
US Patent:
6294170, Sep 25, 2001
Filed:
Aug 7, 1998
Appl. No.:
9/131247
Inventors:
Thomas C. Boone - Newbury Park CA Susan Hershenson - Newbury Park CA Michael P. Bevilacqua - Boulder CO David S. Collins - Fishers IN
Assignee:
Amgen Inc. - Thousand Oaks CA
International Classification:
A61K 3800, A61K 39395
US Classification:
4241341
Abstract:
A protein which exhibits a therapeutic effect on inflammation and is useful for treating IL-1-mediated inflammatory diseases, particularly diseases of the joint.